A mechanism-level guide to the main peptide classes used in cosmetics: copper peptide GHK-Cu for wound repair, collagen synthesis, and tissue remodeling; carnosine for antioxidant and anti-glycation action; glutathione for melanin control and detoxification; plus frog antimicrobial peptides and…
The peptides used in cosmetics fall into five structural and functional families: the copper-binding tripeptide GHK-Cu, the dipeptide carnosine, the tripeptide glutathione, antimicrobial peptides harvested from amphibian skin, and antioxidant peptide fragments derived from soy protein. Each acts through a different molecular route. Copper peptide drives collagen and glycosaminoglycan synthesis in the dermis. Carnosine scavenges free radicals and competes for non-enzymatic glycation. Glutathione suppresses melanin production and conjugates toxic species. Frog antimicrobial peptides disrupt microbial membranes and, in some formulations, assemble into wound-adherent collagen fibers. Soy peptides donate electrons to reactive oxygen species and chelate pro-oxidant metal ions.
For a researcher or buyer comparing ingredients, the relevant question is not which peptide is best, but which mechanism matches the stated skin benefit. Wound healing, anti-aging, whitening, and hydration are four different physiological processes, and no single peptide in this group addresses all four. The evidence base supporting each mechanism is also uneven: some claims rest on registered clinical trials and indexed literature, while others rest on nothing more than a vendor comparison table.
A peptide is any compound of three or more amino acids joined by amide bonds, also called peptide bonds . The bond forms by dehydration condensation between the carboxyl group of one amino acid and the amino group of the next, producing the amide linkage. Size determines nomenclature. Oligopeptides , also called small molecular peptides, contain 2 to 10 amino acids. Polypeptides are defined in one classification scheme as 10 to 50 amino acids, and alternatively as 10 to 100 in some literature. Above 50 amino acids the molecule is generally classified as a protein.
These boundaries are arbitrary and overlap in practice, but they matter for cosmetics for two reasons. Small peptides penetrate the stratum corneum more readily than large proteins. And the three best-documented cosmetic peptides, GHK-Cu, carnosine, and glutathione, all sit at or below the oligopeptide threshold. A definitional wrinkle is worth noting: carnosine is a dipeptide, so by the strict three-or-more rule it is not a peptide at all. Manufacturer literature routinely groups it with cosmetic peptides anyway, because its biology, histidine-based antioxidant chemistry and anti-glycation activity, belongs to the same functional class. A researcher cataloging ingredients should record carnosine as a peptide-like molecule and treat its inclusion in peptide catalogs as a commercial convention.
GHK-Cu , the copper complex of glycyl-histidyl-lysine, is the most-studied cosmetic peptide in this group. Dr. Loren Pickart isolated the tripeptide from human plasma, where it circulates at concentrations that decline with age. The tripeptide spontaneously complexes with divalent copper ions; the resulting coordination compound is sold under names such as Tripeptide-1 Copper and Prezatide Copper. The reported repair mechanism has three arms: stimulation of collagen and glycosaminoglycan production, acceleration of cell proliferation, and activation of tissue remodeling. These effects underlie the ingredient's documented uses in wound healing, scar reduction, and repair of post-acne lesions. The compound also shows antioxidant and anti-inflammatory activity, which is why medical aesthetics uses it for scar repair.
The copper is not a passive passenger in this complex. Divalent copper is a cofactor for lysyl oxidase, the enzyme that crosslinks collagen and elastin, and it participates in the redox chemistry of tissue remodeling. The tripeptide's affinity for copper is what allows it to deliver the metal to wound sites. That coordination chemistry also explains why GHK-Cu is sold as a defined coordination compound rather than as a free tripeptide: the peptide alone and the peptide bound to copper are different molecules with different activities.
Vendor catalogs list several copper peptide variants with distinct stoichiometries. GHK-Cu, catalog CPC1613, has molecular weight 403.94 and formula C14H22CuN6O4. The dimeric form GHK 2·Cu, catalog CPC1658, weighs 744.32 and has formula C28H46CuN12O8. Prezatide Copper, catalog CPC1708, weighs 740.282 with formula C28H44CuN12O8, and Prezatide Copper Acetate, catalog R1966, weighs 862.39 with formula C32H54CuN12O12. Acetyl hexapeptide-3, catalog HB00125, mass 888.99, formula C34H60N14O12S, appears in the same catalog section but is structurally unrelated to the copper complexes; it is a hexapeptide rather than a copper-binding tripeptide, and its placement there reflects catalog organization rather than a shared mechanism. These molecular weights and formulas are catalog entries, so they document what the manufacturer sells, not what the independent literature has verified.
Peptide Atlas records support the clinical interest in GHK-Cu. Two registered clinical trials are on file. NCT07437586 is a Phase 2 trial, currently recruiting, testing topical GHK-Cu gel for healing acute standardized cutaneous wounds, specifically punch-biopsy wounds. NCT05932732 is a completed Phase 4 trial assessing the impact on facial skin quality, hydration, and skin barrier of three Hydrafacial treatments in adults of all skin types. The phase breakdown is one Phase 2 and one Phase 4 trial; the status breakdown is one recruiting and one completed. The indexed literature base is 31 PubMed papers. The indexed papers include behavioral rescue in middle-aged mice treated with the peptide intraperitoneally or intranasally, delayed aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways, attenuation of copper sulfate or lipopolysaccharide-induced inflammation in zebrafish larvae, a dynamic enzyme-mimetic peptide hydrogel for infected inflammatory wounds, and a laccase-like activity that the peptide exhibits in colorimetric sensing of phenolic compounds.
The quality data on file are strong. Five third-party laboratory purity tests are recorded, with the highest observed purity at 99.941 percent. That is the benchmark a buyer should expect from research-grade supply. The documented limitation on copper peptide is economic, not biochemical: use in skincare is not yet widespread mainly because of cost. There is no evidence in the available record that efficacy is the constraint.
Carnosine , β-alanylhistidine, catalog CPC1634, molecular weight 226.23, formula C9H14N4O3, is one of the earliest bioactive peptides used in cosmetics, with chemical synthesis spanning nearly a century. Its antioxidant mechanism is direct. The histidine side chain acts as a hydrogen donor, capturing free radicals and protecting cells from oxidative damage. A second, less established antioxidant route involves inhibition of telomere shortening, a mechanism the source attributes to recent studies without citation, so it should be treated as a hypothesis rather than settled biology.
The best-supported cosmetic role of carnosine is anti-glycation. Non-enzymatic glycation crosslinks structural proteins over time, and the resulting advanced glycation end products stiffen collagen and degrade elasticity. Carnosine acts as a substitute target for that glycation. Because it presents a reactive amine that absorbs glycating species, it competes with structural proteins and prevents the crosslinking that would otherwise damage the dermal matrix. The documented outcomes are preservation of skin elasticity and brightening of skin tone. Carnosine also maintains superoxide dismutase activity and buffers physiological pH, neutralizing large amounts of the lactic acid that muscles produce. That buffering chemistry underlies the claim, listed in a vendor comparison table rather than a cited trial, that carnosine enhances physical strength and endurance in athletics. No peer-reviewed evidence for that claim appears in the record provided.
Four carnosine-related compounds appear in catalogs. The parent molecule, carnosine, catalog CPC1634, is listed above. N-Acetyl Carnosine, catalog 10-101-223, molecular weight 268.27, formula C11H16N4O4, is an acetylated form intended for improved stability. Decarboxy Carnosine HCl, catalog CPC1681, molecular weight 255.14, formula C8H16Cl2N4O, is the decarboxylated analog. L-Homocarnosine, catalog R1914, molecular weight 240.26, formula C10H16N4O3, extends the molecule by one methylene group. All four carry the imidazole ring that performs the hydrogen-donating chemistry.
Carnosine's manufacturing maturity is its commercial advantage. Because synthesis has been practiced for decades, the ingredient is inexpensive and appears in major international skincare brands. A researcher who wants an antioxidant with anti-glycation activity and a long safety history has more data to work with for carnosine than for any peptide in this group except GHK-Cu.
Glutathione is a tripeptide of glutamate, cysteine, and glycine, and it exists in two interconverting forms. Under normal conditions the reduced form, written G-SH, predominates. Oxidation produces the disulfide G-S-S-G, and the enzyme glutathione reductase returns the disulfide to the reduced state. This redox couple is the molecule's fundamental mechanism. Every reported cosmetic and clinical effect of glutathione traces back to the nucleophilic thiol group on the cysteine residue, the most chemically reactive part of the molecule.
The whitening claim is mechanistically specific. Glutathione suppresses melanin production and inhibits tyrosinase, the rate-limiting enzyme of melanogenesis. The source cites study evidence for its effectiveness in treating melasma in women when combined with vitamin C. The detoxification claim is equally specific: the thiol group binds heavy metal ions and drug metabolites, forming non-toxic or low-toxic complexes that are excreted from the body. The same conjugation chemistry underlies the comparison-table claim that glutathione assists in removing toxic substances and repairing liver damage. That indication has a plausible mechanism but no clinical trial in the Peptide Atlas registry to support it.
The Peptide Atlas dataset for glutathione is striking mainly for what it lacks. There are 0 registered clinical trials on file and 20 indexed PubMed papers. The indexed literature clusters around liver injury and redox biology, not cosmetics. One paper reports that a Jin Ge Fang decoction mitigates alcoholic liver injury in rats via modulation of the TLR4/NF-κB signaling axis. Another finds that Lactobacillus casei culture supernatant ameliorates acute alcohol-induced liver injury by inhibiting cellular stress and promoting intestinal integrity in mice. A third reports that the HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. A fourth examines the molecular mechanism of γ-glutamyl transferase from Rhodotorula mucilaginosa in γ-glutamyl peptide biosynthesis. A fifth, on glutathione inducing trap closure for carnivory in the Cape sundew, is a reminder that this thiol is an ancient signaling molecule, not only a mammalian antioxidant.
The gap between this literature base and commercial whitening claims is wide. Zero trials and twenty papers, none of which address human skin pigmentation, is a thin foundation for a category-defining claim. A buyer evaluating glutathione for whitening should look to the melasma literature, where it is used with vitamin C, and should treat the cosmetic-specific evidence as preliminary.
Amphibian skin is a natural source of antimicrobial peptides , defensive molecules 10 to 50 amino acid residues long, distinguished by strong alkalinity and thermal stability. The reported properties are broad-spectrum antimicrobial, antiviral, and anticancer activity, and one comparison table credits them with clinical use in hepatitis treatment. Frog skin oil adds a separate wound-repair mechanism: the oil self-assembles or cross-links into collagen fibers that adhere to wounds, and it contains amino acids, trace elements, and a reportedly high concentration of human chorionic gonadotropin. That gonadotropin claim is presented theoretically in the source, not as demonstrated clinical evidence, and it should be read that way.
Research on frog peptides is comparatively immature. The source documentation states plainly that research and application remain at a relatively early stage, and current development work centers on chitosan composite sponges that improve adhesion and water absorption for topical delivery. The unresolved questions are basic: how delivery via chitosan sponges compares with other systems in bioavailability, and what regulatory and safety assessment would be required before cosmetic use. These peptides are the least ready for commercial formulation of the five families discussed here.
Soy protein-derived antioxidant peptides are the plant counterpart. Preparation by ultrafiltration and enzymatic hydrolysis yields short peptide fragments with high antioxidant activity. Four mechanisms are reported: direct scavenging of hydroxyl radicals, capture of reactive oxygen species, activation of the body's antioxidant enzyme system, and chelation of metal ions that would otherwise catalyze oxidation. Hydroxyl radical scavenging depends on the exposure of amino acid side chains, which hydrolysis achieves by cutting the protein into accessible fragments. Soy peptides also solve two formulation problems of intact soybean protein, poor solubility and instability, and they have the longest development history among plant-derived peptides. Their applications span nutritional supplements, functional foods, and cosmetics.
For a researcher or buyer, the decision matrix follows the mechanism:
Three cautions apply across all five classes. First, the source documentation provides no dosage, concentration, or usage frequency data for any peptide in finished cosmetic formulations. The effective concentration question is unresolved for every compound in this article. Second, the stability of copper peptide in finished products, a known risk for metal-coordinated actives, has no published profile in the available record. Third, the head-to-head question, how copper peptide compares with retinoids or vitamin C for anti-aging and wound healing at cosmetic-use concentrations, has not been answered in the trials on file.
Several claims travel through manufacturer literature without experimental support. The telomere-shortening mechanism of carnosine is attributed to studies described as recent but is not cited. The athletic endurance benefit of carnosine and the liver repair benefit of glutathione both come from a comparison table rather than peer-reviewed trials, and no clinical trial for glutathione is on file at Peptide Atlas. The high human chorionic gonadotropin content of frog skin oil is a theoretical claim. None of these should be repeated as established fact in a research context.
What the record does establish is limited but concrete. GHK-Cu has an active Phase 2 trial in wound healing, a completed Phase 4 trial touching facial hydration and skin barrier, 31 indexed papers, and a highest observed third-party purity of 99.941 percent across five tests. Those are the numbers a researcher can cite. The catalog data in this article, molecular weights and formulas such as 403.94 for GHK-Cu and 226.23 for carnosine, function as identity checks for procurement. What no catalog entry will tell a buyer is the concentration used in the finished product, the stability of the peptide in that base, or whether the claimed benefit survives the trip from the jar to the stratum corneum. Those data do not exist in the public record for cosmetic-use concentrations, and until they do, mechanism-based claims should be labeled as such.
Peptides referenced: GHK-Cu, Argireline, Copper Tripeptide-1, Glutathione, HCG.
Related reading: Animal, Plant and Synthetic Peptides: Sources, Uses and Differences, Condensation Agents in SPPS: Mechanisms and Selection, Peptide Targeting Agents for In Vivo Tumor Imaging: A Practical Primer, Five Enzyme Families That Build Short Oligopeptides and Peptide Drugs.